Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Return on Sales (2016 - 2025)

Historic Return on Sales for Phibro Animal Health (PAHC) over the last 14 years, with Q4 2025 value amounting to 0.07%.

  • Phibro Animal Health's Return on Sales rose 600.0% to 0.07% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.06%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.03% for FY2025, which is 200.0% up from last year.
  • According to the latest figures from Q4 2025, Phibro Animal Health's Return on Sales is 0.07%, which was up 600.0% from 0.07% recorded in Q3 2025.
  • Over the past 5 years, Phibro Animal Health's Return on Sales peaked at 0.08% during Q4 2021, and registered a low of 0.03% during Q3 2023.
  • Its 5-year average for Return on Sales is 0.04%, with a median of 0.03% in 2023.
  • As far as peak fluctuations go, Phibro Animal Health's Return on Sales plummeted by -500bps in 2022, and later surged by 600bps in 2024.
  • Phibro Animal Health's Return on Sales (Quarter) stood at 0.08% in 2021, then tumbled by -61bps to 0.03% in 2022, then tumbled by -83bps to 0.01% in 2023, then soared by 102bps to 0.01% in 2024, then skyrocketed by 613bps to 0.07% in 2025.
  • Its Return on Sales stands at 0.07% for Q4 2025, versus 0.07% for Q3 2025 and 0.03% for Q2 2025.